Showing posts with label trial delays. Show all posts
Showing posts with label trial delays. Show all posts
Tuesday, May 23, 2017

REMOTE Redux: DTP trials are still hard

›
Maybe those pesky sites are good for something after all.  It's been six years since Pfizer boldly announced the launch of its "...
3 comments:
Thursday, September 19, 2013

Questionable Enrollment Math(s) - the Authors Respond

›
The authors of the study I blogged about on Monday were kind enough to post a lengthy comment, responding in part to some of the issues I ...
Monday, September 16, 2013

Questionable Enrollment Math at the UK's NIHR

›
There has been considerable noise coming out of the UK lately about successes in clinical trial enrollment. First, a couple months ago cam...
5 comments:
Thursday, May 30, 2013

Clinical Trial Enrollment, ASCO 2013 Edition

›
Even by the already-painfully-embarrassingly-low standards of clinical trial enrollment in general, patient enrollment in cancer clinical tr...
Friday, January 25, 2013

Less than Jaw-Dropping: Half of Sites Are Below Average

›
Last week, the Tufts Center for the Study of Drug Development unleashed the latest in their occasional series of dire pronouncements about...
2 comments:
Tuesday, December 11, 2012

What (If Anything) Improves Site Enrollment Performance?

›
ENACCT has released its final report on the outcomes from the National Cancer Clinical Trials Pilot Breakthrough Collaborative (NCCTBC) , a...
Tuesday, September 25, 2012

What We Can Anticipate from TransCelerate

›
TransCelerate: Pharma's great kumbaya moment? Last week, 10 of the largest pharmaceutical companies caused quite a hullaballoo in t...